Prolific Parkinson’s Researcher Dr. Alberto J. Espay Joins Pharmather as Scientific Advisor TORONTO, Nov. 11, 2020 – Pharmather Inc., a wholly-owned subsidiary of Newscope Capital Corporation (“Pharmather” or the “Company”) (CSE: PHRM) and a specialty life...
Dr. Hauser to advise Pharmather on the clinical development of ketamine for Parkinson’s Disease TORONTO, Oct. 29, 2020 – Pharmather Inc., a wholly-owned subsidiary of Newscope Capital Corporation (“Pharmather” or the “Company”) (CSE: PHRM) and a specialty life...